Management, Survival, and Costs of Pancreatic Cancer: Population-Based Observational Study in Catalonia.
Laura Guarga-SoléNoelia PacoPaula Manchon-WalshEmili VelaJoaquín Delgadillo-DuarteCaridad PontesJosep Maria BorràsPublished in: International journal of environmental research and public health (2023)
Half of the patients diagnosed with pancreatic cancer did not receive specific treatment. Surgery with curative intent was associated with longer survival, but only 18% of (mostly younger) patients received this treatment. Chemotherapy was also used less frequently in patients of advanced age, though survival in treated patients was comparable across all age groups, so careful oncogeriatric assessment is advisable to ensure the most appropriate indication for eligibility in older patients. In general, earlier diagnosis and more effective pharmacological treatments are necessary to treat frail patients with high comorbidity, a common profile in older patients.